| Q67822633 | A Microbiological Comparison of Young Adults Based on Relative Amounts of Subgingival Calculus |
| Q34202954 | A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients |
| Q77203210 | Actinobacillus actinomycetemcomitans in the human oral microflora |
| Q37033875 | Assessment of serum antibody patterns and analysis of subgingival microflora of members of a family with a high prevalence of early-onset periodontitis |
| Q35977242 | Azithromycin enhances phagocytic killing of Aggregatibacter actinomycetemcomitans Y4 by human neutrophils |
| Q36306223 | Benefits of early systemic antibiotics in localized aggressive periodontitis: a retrospective study |
| Q46025244 | Black-pigmenting Gram-negative bacteria in periodontal disease. II. Screening strategies for detection of P. gingivalis |
| Q35145327 | Can presence or absence of periodontal pathogens distinguish between subjects with chronic and aggressive periodontitis? A systematic review |
| Q36839091 | Cloning and characterization of the Actinobacillus actinomycetemcomitans gene encoding a heat-shock protein 90 homologue |
| Q37036446 | Comparative bacteriology of juvenile periodontitis. |
| Q36471295 | Effect of biologic mediators on ciprofloxacin accumulation by gingival fibroblasts |
| Q43887825 | Effect of the enamel matrix derivative Emdogain on the growth of periodontal pathogens in vitro |
| Q36987457 | Effects of immunization with Porphyromonas gingivalis and Prevotella intermedia on progression of ligature-induced periodontitis in the nonhuman primate Macaca fascicularis |
| Q35862665 | In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans |
| Q44187246 | In vitro antimicrobial susceptibility of oral strains of Actinobacillus actinomycetemcomitans to seven antibiotics |
| Q36758145 | In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations |
| Q44187247 | Local antibiotic therapy guided by microbiological diagnosis |
| Q70291832 | Microbiological and clinical effects of topical subgingival antimicrobial treatment on human periodontal disease |
| Q34308320 | Microbiology of periodontal disease in children and young adults |
| Q36743835 | Myricetin Prevents Alveolar Bone Loss in an Experimental Ovariectomized Mouse Model of Periodontitis |
| Q46549105 | Non-Surgical Therapy Reduces Presence of JP2 Clone in Localized Aggressive Periodontitis |
| Q37011229 | Oxidative and nonoxidative killing of Actinobacillus actinomycetemcomitans by human neutrophils |
| Q24550679 | Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment |
| Q68308654 | Periodontal disease in HIV-infected patients in relation to lymphocyte subsets and specific micro-organisms |
| Q34680895 | Periodontal diseases in the child and adolescent. |
| Q35219134 | Periodontitis as an infectious disease: specific features and their implications |
| Q37979433 | Rationale for the use of antimicrobial agents in periodontal disease |
| Q45088553 | Reevaluation of the chromosome 4q candidate region for early onset periodontitis |
| Q37018061 | Role of high-avidity binding of human neutrophil myeloperoxidase in the killing of Actinobacillus actinomycetemcomitans |
| Q34941942 | Selection of antimicrobial agents in periodontal therapy |
| Q30420919 | Subgingival air-polishing with erythritol during periodontal maintenance: randomized clinical trial of twelve months |
| Q35562713 | Subinhibitory concentrations of tetracycline alter fibrinogen binding by Bacteroides intermedius |
| Q36753848 | Synergistic effects between amoxicillin, metronidazole, and the hydroxymetabolite of metronidazole against Actinobacillus actinomycetemcomitans |
| Q38122682 | Systemic anti-microbial agents used in periodontal therapy |
| Q34639587 | Systemic antibiotics in the treatment of periodontal disease. |
| Q73434186 | Tenacious adhesion of Actinobacillus actinomycetemcomitans strain CU1000 to salivary-coated hydroxyapatite |
| Q31034448 | Tetracyclines Inhibit Connective Tissue Breakdown: New Therapeutic Implications for an Old Family of Drugs |
| Q54174502 | Tetracycline‐resistant micro‐organisms recovered from patients with refractory periodontal disease |
| Q72568635 | The effect of clindamycin gel insert in periodontal pockets, as observed on smears and cultures |
| Q28085417 | The enduring importance of animal models in understanding periodontal disease |
| Q34249696 | The intra-oral translocation of periodontopathogens jeopardises the outcome of periodontal therapy. A review of the literature |
| Q45129042 | The role of Actinobacillus actinomycetemcomitans in periodontal disease |
| Q98464464 | Various Treatment Modalities in Aggressive Periodontitis |
| Q57649761 | [The GTR technic within the framework of combined periodontal-orthodontic treatments. A case report] |